C. Miossec

发表

Use of monoclonal antibodies to study interleukin ‐1β‐converting enzyme expression: only precursor forms are detected in interleukin‐1β‐secreting cells

F. Fassy, L. Durand, A. Diu-Hercend, 1996 .

CD1c as a target recognition structure for human T lymphocytes: Analysis with peripheral blood γ/δ cells

F. Faure, T. Hercend, C. Miossec, 1990 .

In Vitro Antibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates

H. Goossens, A. Girard, K. Coleman, 2012, Antimicrobial Agents and Chemotherapy.

P794 The efficacy of ceftazidime combined with NXL104, a novel β-lactamase inhibitor, in a mouse model of kidney infections induced by β-lactamase producing Enterobacteriaceae

J. Lowther, M. Borgonovi, C. Miossec, 2007 .

Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.

J. de Gunzburg, M. Wilcox, A. Andremont, 2020, The Journal of antimicrobial chemotherapy.

T cell target 1 (TCT.1): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytes

F. Mami-Chouaib, P. Del Porto, C. Flament, 1990, The Journal of experimental medicine.

Molecular characterization of human T cell receptor α chains including a Vδ1‐encoded variable segment

S. Roman-Roman, L. Ferradini, F. Faure, 1991 .

Multidrug-Resistant Escherichia coli in Bovine Animals, Europe

D. Hurley, Juan Wang, S. Srikumar, 2016, Emerging infectious diseases.

Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell lines.

W. Fridman, C. Mathiot, S. Amigorena, 1988, Molecular immunology.

Enzymatic activity of two caspases related to interleukin-1beta-converting enzyme.

F. Fassy, C. Capdevila, C. Faucheu, 1998, European journal of biochemistry.

Further analysis of the T cell receptor gamma/delta+ peripheral lymphocyte subset. The V delta 1 gene segment is expressed with either C alpha or C delta

S. Roman-Roman, L. Ferradini, F. Faure, 1990, The Journal of experimental medicine.

CD3.TCR1, A Human CD3 epitope expressed on viable γδ lymphocytes exclusively

T. Hercend, C. Miossec, S. Jitsukawa, 1992 .

In Vitro Antibacterial Activity of the Ceftazidime-Avibactam Combination against Enterobacteriaceae, Including Strains with Well-Characterized β-Lactamases

A. Girard, K. Coleman, J. Pace, 2015, Antimicrobial Agents and Chemotherapy.

Evidence for an interleukin-1β converting enzyme (ICE)-like activity distinct from ICE and responsible for ICE and CPP32 cleavage during apoptosis

F. Fassy, C. Faucheu, L. Durand, 2004, Apoptosis.

A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells.

M. Su, J. Lippke, Y. Gu, 1995, The EMBO journal.

A study of the correlation between phenotypic antimicrobial susceptibility testing methods and the associated genotypes determined by whole genome sequencing for a collection of Escherichia coli of bovine origin

Scott V. Nguyen, S. Fanning, F. Woehrlé, 2021, bioRxiv.

In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

A. Girard, T. Stachyra, M. T. Black, 2009, The Journal of antimicrobial chemotherapy.

Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model

G. Drusano, A. Girard, D. Shlaes, 2014, Antimicrobial Agents and Chemotherapy.

Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor

J. Frère, T. Stachyra, K. Coleman, 2010, Antimicrobial Agents and Chemotherapy.

High genetic diversity in methicillin-susceptible Staphylococcus pseudintermedius in dogs in Europe.

B. Valot, D. Hocquet, F. El Garch, 2020, Journal of global antimicrobial resistance.

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.

N. Woodford, D. Livermore, M. Warner, 2008, The Journal of antimicrobial chemotherapy.

Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens

C. Auffray, D. Piatier‐Tonneau, B. Huard, 1992, The Journal of experimental medicine.

Characterization of the Lymphocyte Activation Gene 3Encoded 3Encoded 3Encoded Protein . A New Ligand for Human Leukoc 3 ~ Antigen Class H Antigens By

C. Auffray, D. Piatier‐Tonneau, B. Huard, 2003 .

Efficacy of a Ceftazidime-Avibactam Combination in a Murine Model of Septicemia Caused by Enterobacteriaceae Species Producing AmpC or Extended-Spectrum β-Lactamases

A. Girard, K. Coleman, J. Pace, 2014, Antimicrobial Agents and Chemotherapy.

Evidence for CPP32 Activation in the Absence of Apoptosis during T Lymphocyte Stimulation*

F. Fassy, A. Diu-Hercend, C. Miossec, 1997, The Journal of Biological Chemistry.

Characterisation of Early Positive mcr-1 Resistance Gene and Plasmidome in Escherichia coli Pathogenic Strains Associated with Variable Phylogroups under Colistin Selection

J. Bono, P. O'Gaora, Guerrino Macori, 2021, Antibiotics.

The gamma/delta T cell receptor expressed on human peripheral blood lymphocytes.

F. Faure, T. Hercend, F. Triebel, 1990, European Cytokine Network.

Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases

D. Platel, A. Girard, T. Stachyra, 2008, Antimicrobial Agents and Chemotherapy.

Molecular characterization of human T cell receptor alpha chains including a V delta 1-encoded variable segment.

S. Roman-Roman, L. Ferradini, F. Faure, 1991, European journal of immunology.

Cloned CD3+ TcR alpha/beta- Ti gamma A- peripheral blood lymphocytes compared to the Ti gamma A+ counterparts: structural differences of the gamma/delta receptor and functional heterogeneity.

F. Faure, T. Hercend, F. Triebel, 1988, European journal of immunology.

Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis

J. de Gunzburg, A. Andremont, T. Nguyen, 2017, Antimicrobial Agents and Chemotherapy.

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.

N. Woodford, D. Livermore, M. Warner, 2008, The Journal of antimicrobial chemotherapy.

Multidrug-Resistant Escherichia coli in Bovine Animals, Europe

D. Hurley, Juan Wang, S. Srikumar, 2016, Emerging infectious diseases.

DAV131, AN ORAL ADSORBENT-BASED PRODUCT, FULLY PROTECTS HAMSTERS AGAINST MOXIFLOXACIN-INDUCED CLOSTRIDIUM DIFFICILE LETHAL INFECTION

A. Andremont, E. Chachaty, T. Murphy, 2012 .